Skip navigation

maximizing solubility. boosting bioavailibility


The Experts

Opportunities to join one of the world's leading teams

News

Services

 

preclinical prototypes

Identify the best formulation
Identifying the best way to formulate the compound can save precious time by a) reducing the number of preclinical studies and b) speeding up the entry of the compound into Man.

Dependable formulations
We aim to develop dependable formulations that are always suitable for further clinical development. At this stage, it is important to ensure the formulation can be developed safely and efficiently for first in Man evaluation.

The Preclinical Prototype Development service focuses on:

  • Identifying formulation strategies tailored to the compound
  • For oral projects, the development of a broad range of initial prototypes for an initial round of in vivo testing
  • Delivery of samples of the Preclinical Prototypes for in vivo testing with supporting accelerated stability testing
  • Typically takes between 8 and 12 weeks and usually requires 1-5g of API

Reduce risk
Excipients and processes are specifically chosen to conform to the regulatory standards of clinical trials, therefore reducing the risk during further development. In this way, the preclinical prototypes are very representative of the future clinical dosage form.

 
 

Back to top